| Reagan-Udall Foundation

Read more about Improving Health Status in COVID-19 Long-Hauler

Read more about A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

The Reagan-Udall Foundation for the FDA is leading an initiative to identify holistic approaches to address opportunities and challenges in animal health and veterinary medicine.

Coverage

Read more about American Association of Swine Veterinarians: Survey: Addressing Unmet Need Within the Animal and Veterinary Industries

In establishing the Hub, FDA gathered feedback from stakeholders through a public meeting, held on Oct. 16, 2024 in collaboration with the Reagan-Udall Foundation.

Coverage

Read more about Pharmaceutical Technology: FDA Rare Disease Innovation Moves Forward

In collaboration with the Reagan-Udall Foundation for the FDA, we hosted a public meeting, Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub, on October 16, 2024.

Coverage

Read more about U.S. Food & Drug Administration: FDA Takes Exciting Steps Toward Establishing the Rare Disease Innovation Hub

Federal agencies recently convened in a pivotal public meeting, hosted by the Reagan-Udall Foundation for the U.S. Food and Drug Administration (FDA), to discuss emerging treatments for post-traumatic stress disorder (PTSD), with a focus on the potential of psychedelics.

Coverage